Xvivo Perfusion AB (publ) (STO:XVIVO)

Sweden · Delayed Price · Currency is SEK

226.20

+6.80 (3.10%)

Oct 15, 2026, 4:18 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Abdominal	225.32M	179.42M	134.04M	70.86M	53.71M
Services	77.53M	87.76M	79.14M	48.08M	6.05M
Thoracic	509.32M	555.24M	384.36M	296.35M	198.63M
Total	812.17M	822.42M	597.54M	415.29M	258.39M

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
USA	427.88M	471.54M	308.10M	224.87M	119.64M
Americas, Excl USA	22.26M	36.29M	25.62M	25.49M	19.03M
APAC	49.20M	43.33M	42.18M	18.81M	13.38M
Sweden	6.69M	3.99M	4.22M	1.67M	2.29M
EMEA Excluding Sweden	306.13M	267.27M	-	-	-
The Netherlands	-	-	30.22M	25.99M	19.42M
Italy	-	-	58.93M	21.48M	14.78M
EMEA Excluding Sweden,Netherlands and Italy	-	-	128.28M	96.99M	69.84M
Total	812.17M	822.42M	597.54M	415.29M	258.39M